Sana Biotechnology (SANA) Depreciation & Amortization (CF) (2020 - 2026)

Sana Biotechnology's Depreciation & Amortization (CF) history runs 7 years deep, the most recent figure standing at $2.4 million for Q1 2026.

• In Q1 2026, Depreciation & Amortization (CF) fell 33.58% year-over-year to $2.4 million; the TTM figure through Mar 2026 stood at $11.6 million (down 24.73% YoY), while the FY2025 annual figure was $12.8 million, down 17.42% from the prior year.
• Depreciation & Amortization (CF) came in at $2.4 million for Q1 2026 at Sana Biotechnology, down from $3.1 million in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $4.5 million in Q2 2023 to a low of $2.4 million in Q1 2026.
• A 5-year average of $3.8 million and a median of $3.8 million in 2022 frame the typical range for Depreciation & Amortization (CF).
• Across the five-year window, Depreciation & Amortization (CF) jumped 60.21% in 2022 and tumbled 33.58% in 2026, its largest moves.
• Sana Biotechnology's Depreciation & Amortization (CF) stood at $4.2 million in 2022, then changed by 0.0% to $4.2 million in 2023, then declined by 9.52% to $3.8 million in 2024, then decreased by 18.42% to $3.1 million in 2025, then dropped by 22.87% to $2.4 million in 2026.
• According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $2.4 million, $3.1 million, and $3.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison